Does CARBOCYSTEINE Cause Malignant neoplasm progression? 6 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Malignant neoplasm progression have been filed in association with CARBOCYSTEINE. This represents 0.9% of all adverse event reports for CARBOCYSTEINE.
6
Reports of Malignant neoplasm progression with CARBOCYSTEINE
0.9%
of all CARBOCYSTEINE reports
5
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CARBOCYSTEINE?
Of the 6 reports, 5 (83.3%) resulted in death, 5 (83.3%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARBOCYSTEINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does CARBOCYSTEINE Cause?
Lower respiratory tract infection (110)
Rash (107)
Off label use (94)
Pulmonary pain (90)
Product dose omission issue (88)
Arthropathy (83)
Condition aggravated (82)
Abdominal discomfort (79)
Overdose (78)
Drug abuse (77)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CARBOCYSTEINE Alternatives Have Lower Malignant neoplasm progression Risk?
CARBOCYSTEINE vs CARBOMER
CARBOCYSTEINE vs CARBON DIOXIDE
CARBOCYSTEINE vs CARBON MONOXIDE
CARBOCYSTEINE vs CARBOPLATIN
CARBOCYSTEINE vs CARBOPROST TROMETHAMINE